Evidence map›Paper›PMID 27878433›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.

L Ke, S-B Xu, J Wang, X-L Jiang, M-Q Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. LncRNA-ATB in cancers: what do we know so far?Molecular biology reports · 2020
    Review
  9. Review
  10. Role of lncRNA-ATB in ovarian cancer and its mechanisms of action.Experimental and therapeutic medicine · 2020
    Article
  11. An Overview ofBioMed research international · 2020
    Review
  12. Article
  13. Article
  14. Non-coding RNAs in lung cancer.Journal of thoracic disease · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

L KeDepartment of Thoracic Surgery, Anhui Provincial Hospital, No. 17 Lujiang Road, Hefei, 230000, China.
S-B XuDepartment of Thoracic Surgery, Anhui Provincial Hospital, No. 17 Lujiang Road, Hefei, 230000, China.
J WangDepartment of Thoracic Surgery, Anhui Provincial Hospital, No. 17 Lujiang Road, Hefei, 230000, China.
X-L JiangDepartment of Thoracic Surgery, Anhui Provincial Hospital, No. 17 Lujiang Road, Hefei, 230000, China.
M-Q XuDepartment of Thoracic Surgery, Anhui Provincial Hospital, No. 17 Lujiang Road, Hefei, 230000, China. xu_meiq@163.com.
Anhui Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimLong non-coding RNAs (lncRNAs) have been demonstrated to act as a critical regulator in the processes of tumor biology. In this study, whether lncRNA-ATB is a potential indicator for non-small cell lung cancer (NSCLC) was investigated and its biological function in NSCLC was also determined.

methodsThe expression levels of lncRNA-ATB in NSCLC tissues and cell lines were measured. A549 cell line was explored to investigate the functions of lncRNA-ATB in NSCLC.

resultsReal-time PCR results showed that lncRNA-ATB expression was up-regulated in both in NSCLC tissues and cell lines. High lncRNA-ATB expression in tumor tissue was associated with larger tumor size, lymph node metastasis, and distant metastasis in patients with NSCLC, respectively. In addition, the patients with high expression of lncRNA-ATB presented a lower survival probability. In vitro experiments showed that down-regulation of lncRNA-ATB promoted the cell apoptosis, whereas inhibited the cell viability, cell migration, and cell invasion.

conclusionHigh expression of lncRNA-ATB indicated a poor prognosis and led to the cell proliferation and metastasis in NSCLC.

Indexed as

Cell ProliferationA549 CellsAgedBiomarkers, TumorCarcinoma, Non-Small-Cell LungFemaleFlow CytometryGene Knockdown TechniquesHumansKaplan-Meier EstimateLung NeoplasmsMaleMiddle AgedNeoplasm InvasivenessPrognosisReal-Time Polymerase Chain ReactionBiomarkers, Tumorlong non-coding RNA ATB, humanRNA, Long NoncodinglncRNA-ATBNon-small cell lung cancerPrognosisTumor biology

Identifiers

PMID27878433
OpenAlexW2553547515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.